Advances in AAV technology create new way forward for gene therapy in CNS diseases
Advances in the field of delivering gene therapies to the CNS through improved AAV tropism and efficiency are yielding new technologies that present a promising way to deliver therapeutics safely, and effectively across key regions of the brain. The TRACER™️ AAV capsid screening platform is discovering novel AAV9 and AAV5 variants with desirable characteristics across non-human primates and rodents, which may lead to successful translation into humans. Learn more.
Proton cancer centers proliferate despite shaky benefits; warning signs for monkeypox outbreak went unheeded
Reviewed by Knowledge World
on
May 26, 2022
Rating: 5
Post Comment
No comments